Peptidase (DPP-4 Inhibitors)
Also known as: dipeptidyl peptidase-4 inhibitor, DPP-4i, gliptin, sitagliptin, saxagliptin, vildagliptin, linagliptin
Effective Dosage
No established dose for supplement use; pharmaceutical doses vary by drug (e.g., sitagliptin 100 mg/day, saxagliptin 5 mg/day)
What the Science Says
Peptidase, in the context of these studies, refers to DPP-4 (dipeptidyl peptidase-4) inhibitors — a class of prescription medications that block an enzyme responsible for breaking down gut hormones called incretins. By preserving these hormones, DPP-4 inhibitors help the body release more insulin after meals and lower blood sugar in people with type 2 diabetes. Research also suggests they may reduce postprandial triglycerides, lower the risk of osteoarthritis, and potentially reduce aspiration pneumonia risk in certain patients.
What It Doesn't Do
Not a proven weight-loss supplement on its own — modest weight effects seen only in combination with other drugs. Not a replacement for lifestyle changes in diabetes management. Not shown to cure or reverse diabetes. No evidence supporting use in healthy adults without diabetes. Not a joint supplement you can just buy off the shelf.
Evidence-Based Benefits
Peptidase, in the context of these studies, refers to DPP-4 (dipeptidyl peptidase-4) inhibitors — a class of prescription medications that block an enzyme responsible for breaking down gut hormones called incretins. By preserving these hormones, DPP-4 inhibitors help the body release more insulin after meals and lower blood sugar in people with type 2 diabetes. Research also suggests they may reduce postprandial triglycerides, lower the risk of osteoarthritis, and potentially reduce aspiration pneumonia risk in certain patients.
Moderate EvidenceEffective at: No established dose for supplement use; pharmaceutical doses vary by drug (e.g., sitagliptin 100 mg/day, saxagliptin 5 mg/day)
Source: auto-research
Absorption & Bioavailability
Unknown for supplement-grade peptidase enzymes; pharmaceutical DPP-4 inhibitors have well-characterized oral bioavailability, but this does not apply to over-the-counter enzyme products
Red Flags to Watch For
- DPP-4 inhibitors are prescription-only drugs — any supplement claiming equivalent effects is unsubstantiated
- DPP-4 inhibitors have been linked to a rare but serious side effect: bullous pemphigoid (a blistering skin condition), especially in elderly patients
- The research in these papers is on pharmaceutical drugs, not the digestive enzyme supplements sold in health stores — do not conflate the two
- Supplement products labeled 'peptidase' are digestive enzymes, not DPP-4 inhibitors — the clinical evidence here does not apply to those products
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-10